![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, July 30, 2020 1:40:03 PM
They're probably under a ton of pressure since their sales are declining and their shareholders are probably pissed and want their management to change things up. The complete opposite over here :)
Insane Psychemedics had to cancel their streak of 94 consecutive dividend payments so their shareholders aren't too happy with that either.
But it makes sense strategically to combine the "alternative" testing approaches to saliva/blood/urine under one company for better sales coverage. I think financial engineering-wise it also makes sense since $PCHM is undervalued largely because it's an unknown OTC so if you put Psychemedics's earnings multiple on $PCHM, $PCHM looks drastically undervalued in comparison.
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM